Ars Pharmaceuticals Inc(SPRY:US)
Market Cap$399.19M
Key Metrics
Price$4.02
Revenue (TTM)$98.99M
Holders Revenue (TTM)-
Gross Profit (TTM)$73.37M
Earnings (TTM)-$197.98M
EBITDA (TTM)-$189.78M
Op. Margin (TTM)-204.49%
Dividend Yield-
Holders Yield-
Cash on hand$24.32M
Total Assets$287.57M
Net Assets$61.31M
Total Debt$96.52M
Key Metrics
Price$4.02
Revenue (TTM)$98.99M
Holders Revenue (TTM)-
Gross Profit (TTM)$73.37M
Earnings (TTM)-$197.98M
EBITDA (TTM)-$189.78M
Op. Margin (TTM)-204.49%
Dividend Yield-
Holders Yield-
Cash on hand$24.32M
Total Assets$287.57M
Net Assets$61.31M
Total Debt$96.52M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $22.68M | $28.09M | $32.5M | $15.72M | $7.97M | $86.58M | $2.07M | $500K | $0 | $0 | $0 | $10K | $20K | $0 | $189K | $464K | $663K |
Cost of Revenue | $6.29M | $6.15M | $8.19M | $4.98M | $1.09M | $865K | $112K | - | - | - | $0 | - | - | - | - | - | - |
Gross Profit | $16.4M | $21.93M | $24.31M | $10.73M | $6.88M | $85.72M | $1.96M | - | - | - | $0 | - | - | - | - | - | - |
| $76.54M | $63.4M | $77.5M | $58.35M | $44.06M | $38.52M | $23.7M | $15.84M | $13.19M | $10.23M | $17.98M | $20.61M | $18.73M | $15.44M | $6.82M | $6.81M | $7.76M | |
| Research and Development | $4.34M | $3.44M | $2.75M | $4.04M | $2.95M | $3.03M | $4.42M | $6.9M | $5.23M | $3.4M | $3M | $7.31M | $6.55M | $4.71M | $3.89M | $4.35M | $5.42M |
| Selling, General, and Administrative | $72.2M | $59.96M | $74.75M | $54.31M | $41.1M | $35.49M | $19.28M | $8.94M | $7.96M | $6.82M | $14.98M | $13.31M | $12.18M | $10.73M | $2.93M | $2.46M | $2.34M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$60.15M | -$41.47M | -$53.19M | -$47.61M | -$37.18M | $47.2M | -$21.75M | -$15.34M | -$13.19M | -$10.23M | -$17.98M | -$20.6M | -$18.71M | -$15.44M | -$6.63M | -$6.34M | -$7.1M |
| -$473K | - | $2.04M | $2.73M | $3.24M | $3.03M | $2.62M | $2.82M | $2.9M | $3.06M | $3.11M | $3.23M | $3.75M | $1.01M | $47K | -$76K | -$151K | |
| Non-Operating Interest Income | $1.97M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Non-Operating Interest Expense | $2.44M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | - | - | $2.04M | $2.73M | $3.24M | $3.03M | $2.62M | $2.82M | $2.9M | $3.06M | $3.11M | $3.23M | $3.75M | $1.01M | $47K | -$76K | -$151K |
Income Before Tax | -$60.62M | -$41.4M | -$51.15M | -$44.88M | -$33.94M | $50.22M | -$19.13M | -$12.52M | -$10.29M | -$7.17M | -$14.87M | -$17.37M | -$14.96M | -$14.43M | -$6.58M | -$6.42M | -$7.25M |
Income Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -$60.62M | -$41.32M | -$51.15M | -$44.88M | -$33.94M | $49.93M | -$19.13M | -$12.52M | -$10.29M | -$7.17M | -$14.87M | -$17.37M | -$14.96M | -$14.43M | -$6.58M | -$6.42M | -$7.25M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$60.62M | -$41.32M | -$51.15M | -$44.88M | -$33.94M | $49.93M | -$19.13M | -$12.52M | -$10.29M | -$7.17M | -$14.87M | -$17.37M | -$14.96M | -$14.43M | -$6.58M | -$6.42M | -$7.25M |
Shares Outstanding (Basic) | 99.3M | - | 98.81M | 98.36M | 98.06M | - | 97.03M | 96.83M | 96.49M | - | 95.58M | 94.91M | 94.23M | - | 93.77M | 93.77M | 93.77M |
Shares Outstanding (Diluted) | 99.3M | - | 98.81M | 98.36M | 98.06M | - | 97.03M | 96.83M | 96.49M | - | 95.58M | 94.91M | 94.23M | - | 93.77M | 93.77M | 93.77M |
EPS (Basic) | -$0.61 | - | -$0.52 | -$0.46 | -$0.35 | - | -$0.20 | -$0.13 | -$0.11 | - | -$0.16 | -$0.18 | -$0.16 | - | -$0.07 | -$0.068 | -$0.077 |
EPS (Diluted) | -$0.61 | - | -$0.52 | -$0.46 | -$0.35 | - | -$0.20 | -$0.13 | -$0.11 | - | -$0.16 | -$0.18 | -$0.16 | - | -$0.07 | -$0.068 | -$0.077 |
EBIT | -$58.18M | -$30.8M | -$53.19M | -$47.61M | -$37.18M | $47.2M | -$21.75M | -$15.34M | -$13.19M | -$10.23M | -$17.98M | -$20.6M | -$18.71M | -$15.44M | -$6.63M | -$6.34M | -$7.1M |
EBITDA | -$58.18M | -$30.8M | -$53.19M | -$47.61M | -$37.18M | $47.2M | -$21.75M | -$15.34M | -$13.19M | -$10.23M | -$17.98M | -$20.6M | -$18.71M | -$15.14M | -$6.62M | -$6.34M | -$7.05M |